RightEye’s Parkinson’s test just took a big step forward. Now it's eyeing a $15M funding round.

The next round of funding would help take the Bethesda company “from adolescence to adulthood,” said co-founder and CEO Adam Gross.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.